Recent developments in the interactions between caveolin and pathogens

Advances in Experimental Medicine and Biology

Volumn 729, Issue , 2012, Pages 65-82

  MacHado, Fabiana S ^a   Rodriguez, Nilda E ^b   Adesse, Daniel ^c   Garzoni, Luciana R ^c   Esper, Lisia ^a   Lisanti, Michael P ^d   Burk, Robert D ^e   Albanese, Chris ^f   Van Doorslaer, Koenraad ^e   Weiss, Louis M ^e   Nagajyothi, Fnu ^e   Nosanchuk, Joshua D ^e   Wilson, Mary E ^b   Tanowitz, Herbert B ^e  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY OF IOWA   (United States)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

^e ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^f GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL TOXIN; CAVEOLIN; CAVEOLIN 1; CAVEOLIN 2; CAVEOLIN 3; CLATHRIN;

ARTICLE; BACTERIAL VIABILITY; BACTERIAL VIRULENCE; CAMPYLOBACTER JEJUNI; CANDIDA ALBICANS; CAVEOLA; CELL COMPARTMENTALIZATION; CELL MIGRATION; CELL STRUCTURE; ENDOCYTOSIS; ESCHERICHIA COLI; FUNGAL VIRULENCE; HISTOPLASMA CAPSULATUM; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INTERNALIZATION; JC VIRUS; LEISHMANIA; LIPID RAFT; NONHUMAN; PAPILLOMA VIRUS; PARACOCCIDIOIDES BRASILIENSIS; PARASITE DEVELOPMENT; PARASITE TRANSMISSION; PARASITE VIABILITY; PARASITE VIRULENCE; PLASMODIUM; PNEUMOCYSTIS; PRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PSEUDOMONAS AERUGINOSA; SIGNAL TRANSDUCTION; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI; VIRUS ENTRY; VIRUS VIABILITY; VIRUS VIRULENCE;

ANIMALS; CAVEOLINS; HOST-PATHOGEN INTERACTIONS; HUMANS; INFECTION;

FUNGI; PROTOZOA; TOXOPLASMA GONDII; TRYPANOSOMA CRUZI;

EID: 84859803429     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-1222-9_5     Document Type: Article

References (131)

1. Duncan MJ, Shin J-S, Abraham SN. Microbial entry through caveolae: Variations on a theme. Cellular Microbiol 2002; 4:783-78 1.
2. Cohen AW, Hnasko R, Schubert Wet al. Role of caveolae and caveolins in health and disease. Physiol Rev 2004; 84:1341-1379.
3. Suzuki T, Suzuki Y. Viral infection and lipid rafis. Biol Pharmacol Bull 2006; 29:1538-1541.
4. Zaas D, Swan Z, Brown BJ et al. The expanding role of caveolinproteins in microbial pathogenesis. Commun Integr Biol 2009; 2:535-537.
5. Shin JS, Abraham SN. Caveolae as portals of entry for microbes. 2001; Microbes Inf3:755-761.
6. Li J, Scherl A, Medina F et al. Impaired phagocytosis in caveolin-1 deficient macrophages. Cell Cycle 2005; 4:1599-607
7. Medina FA, Williams TM, Sotgia F et al. A novel role for caveolin-1 in B lymphocyte function and the development of thymus-independent immune responses. Cell Cycle 2006; 5:1865-1871.
8. Pelkmans L, Kartenbeck J, Helenius A. Caveolar endocytosis of simian virus 40 reveals a new two-step vesiculartransport pathway to the ER. Nat Cell Biol 2001; 3:473-483.
9. Norkin LC, Anderson HA, Wolfrom SA et al. Caveolar endocytosis of simian virus 40 is followed by brefeldin A-sensitivetransporttothe endoplasmicreticulum, wherethevirus disassembles. JVirol 2002; 76:5156-5166.
10. Hawkins BT, Davis TP. The blood-brain barrier neurovascular unit in health and disease. Phamiacol Rev 2005; 57:173-185.
11. Abbott NJ, Ronnbllck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rv Neurosci 2006; 7:41-53.
12. Weiss JM, Nath A, Major EO et al. HIV-1 Tat induces monocyte chemoattractant protein-i mediated monocyte trans migration across a model of the human blood brain barrier and upregulates CCR5 expression on human monocytes. J Immunol 1999; 163:2953-2959.
13. Zhong Y, Smaet EJ, Weksler B et al. Caveolin-1 regulates HIV-1 Tat-induced alterations of tight junction protein expression via modulation of the RAS signaling. J Neurosci 2008; 28:7788-7796.
14. Munoz N, Castellsague X, de Gonzalez AB et al. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24S3:S1-S10.
15. Baker TS, Newcomb WW, Olson NH et al. Structures of bovine and human papillomaviruses. Analysis by cryoelectron microscopy and three-dimensional image reconstruction.Biophys J 1991;60: 1445-1456.
16. Richards RM, Lowy DR, Schiller JT et al. Cleavage of the papillomavirus minor capsid protein, L2, at a flirin consensus site is necessary for infection. Proc Natl Acad Sci USA 2006; 103:1522-1527.
17. Kines RC, Thompson CD, Lowy DR et al. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Proc Natl Acad Sci US A 2009; 106:20458-20463.
18. Bousarghin L, Touze A, Sizaret PY et al. Humanpapillomavirus types 16,31 and 58 use different endocytosis pathways to enter cells. J Virol 2003; 77:3846-3850.
19. Day PM, Lowy DR, Schiller JT. Papillomaviruses infect cells via a clathrin-dependent pathway. Virology 2003; 307:1-11.
20. Hindmarsh PL, Laimins LA. Mechanisms regulating expression of the HPV 31 Li and L2 capsid proteins and pseudovirion entry. Virol J 2007; 4:19.
21. Selinka HC, Giroglou T, Sapp M. Analysis of the infectious entry pathway of human papillomavirus type 33 pseudovirions. Virology 2002; 299:279-287.
22. Smith J L, Campos SK, Ozbun MA. Human papillomavirus type 31 uses a caveolin 1-and dynamin 2-mediated entry pathway for infection of human keratinocytes. J Virol 2007; 81:9922-9931.
23. Spoden G, Freitag K, Husmann et al. Clathrin-and caveolin-interdependent entry of human papillomavirus typeló-involvement of tetraspanin-enriched microdomains (TEM5). Pbs One 2008; 3:e3313.
24. Yan M, Peng J, Jabbar IA et al. Despitedifferences between dendritic and Langerhans cells inthe mechanism ofpapillomavirus-likeparticle antigenupdate, bothcells cross-prime T-cells. Virology 2004; 324:297-310.
25. Querbes W, O'Hara BA, Williams G et al. Invasion of host cells by JC virus identifies a novel role for caveolae in endosomal sorting of noncaveolar ligands. J Virol 2006; 80:9402-9413.
26. Laniosz V, Dabydeen SA, Havens MA et al. Humanpapillomavirus type 16 infection ofhumankeratinocytes requires clathrin and caveolin-1 and is brefeldin a sensitive. J Virol 2009; 83:8221-32.
27. Laniosz V, Holthusen KA, Meneses PT. Bovine papillomavirus type 1: From clathrin to caveolin. J Virol 2008; 82:6288-6298.
28. Smith JL, Campos SK, Wandinger-Ness A. Ozbun. Caveolin-1-dependent infectious entry of human papillomavirus type 31 in human keratinocytes proceeds to the endosomal pathway for pH-dependent uncoating. J Virol 2008; 82:9505-95 12.
29. Duncan MJ, Li G, Shin JS et al. Bacterial penetration of bladder epithelium through lipid rafis. J Biol Chem 2004; 279:18944-18951.
30. Watson RO, Galán JE. Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog 2008; 4:e14.
31. Ganean S, Gao XP, Brovkovych Vet al. Caveolin-1 regulates NF-kappaB activation and lung inflammatory response to sepsis induced by lipopolysaccharide. J Immunol 2006; 177:4853-4860.
32. Medina FA, de Almeida CJ, Dew E et al. Caveolin-1-deficient mice show defects in innate immunity and inflammatory immune response during Salmonella enterica serovar Typhimurium infection. Infect Immun 2006; 74:6665-6674.
33. Lyczak JB, Cannon CL, Pier GB et al. Lung infections associated with cystic fibrosis. Clin Microbiol rev 2002; 15:194-222.
34. Zeitlin PT. Pseudomonas aeruginosa: Can studies in engineered cells tell us why is it such a problem in people with cystic fibrosis? Focus on "Cystic fibrosis transmembrane conductance regulator andcaveolin-1 regulate epithelial cell internalization of Pseudomonas aeruginosa" Am J Physiol Cell Physiol 2009; 297 :C23 5-C237.
35. Kowalski MP, Pier G. Localization of cystic fibrosis transmembrane conductance regulator to lipid rafis of epithelial cells is required for Pseudomonas aeruginosa-induced cellular activation. J Immunol 2004; 172:418-425.
36. Grassmé H, Becker KA, Zhang Y et al. Ceramide in bacterial infections and cystic fibrosis. Biol Chem 2008; 389:1371-1379.
37. Grassmé H, Becker KA, Zhang Yet al. Ceramide in Pseudomonas aeruginosa infections and cystic fibrosis. Cell Physiol Biochem 2010; 26:57-66.
38. PierGB, Grout M,Zaidi TS. Cysticfibrosis transmembrane conductance regulatoris an epithelial cell receptor for clearance of Pseudomonas aeruginosa from the lung. Proc Natl Acad Sci USA 1997; 94:12088-12093.
39. Abraham SN, Duncan MJ, LI G et al. Bacterial penetration of the mucosal banier by targeting lipid rafis. J Investig Med 2005; 53:318-321.
40. Bajmoczi M, Gadjeva M, Alper SL et al. Cystic fibrosis transmembrane conductance regulator and caveolin-1 regulate epitheial cell intemalization of Pseudomonasaemginosa.Am J Physiol Cell Physiol 2009 297:C263-277.
41. Gadjeva M, Paradis-Bleau C, Priebe GP et al. Caveolin-1 modifies the immunityto Pseudomonas aeruginosa. J Immunol 2010; 184:296-302.
42. Alvar J, Aparicio P, AseffaA et al. The relationship between Leishmaniasis and AIDS: The second 10 years. Clin microbial Rev 2008; 21:334-359.
43. McConville M J, Turco SJ, Ferguson MA et al. Developmental modification of lipophosphoglycan during the differentiation of Leishmania major promastigotes to an infectious stage. EMBO J 1992; 11:3593-3600.
44. Sacks DL, Pimenta PF, McConville MJ et al. Stage-specific binding of Leishmania donovani to the sand fly vector midgut is regulated by conformational changes in the abundant surface lipophosphoglycan. J Exp Med 1995; 181:685-697.
45. Yao C, Chen Y, Sudan B et al. Leishmania chagasi: Homogenous metacyclic promastigotes isolated by buoyant density are highly virulent in a mouse model. Exp Parasitol 2008; 118:129-133.
46. Bogdan C, Rollinghoff M. How do protozoan parasites survive inside macrophages? Parasitol Today 1999; 15:22-28.
47. Galvao-Quintao L, Alfieri SC, Ryter A. Intracellular differentiation of Leishmania amazonensis promastigotes to amastigotes: Presence of megasomes, cysteine proteinase activity and susceptibility to leucine-methyl ester. Parasitology 1990; 101 Pt 1:7-13.
48. Wilson ME, limes DJ, SousaAD. Early histopathology of experimental infection with Leishmaniadonovani in hamsters. J Parasitol 1987; 73:55-63.
49. Banal A, Banal-Netto M, Yong EC et al. Transforming growth factor β as a virulence mechanism for Leishmania braziliensis. Proc Natl Acad Sci U S A 1993; 90:3 442-3446.
50. Channon TV, Roberts MB, Blackwell JM. A study of the differential respiratory burst activity elicited by promastigotes and amastigotes of Leishmania donovani in murine resident peritoneal macrophages. Immunology 1984; 53:345-355.
51. Gantt KR, Schultz-Cheny S, Rodriguez Net al. Activation of TGF-β by Leishmania chagasi: Importance for parasite survival in macrophages. J Immunol 2003; 70:26 13-2620.
52. Meier CL, Svensson M, Kaye PM. Leishmania-induced inhibition of macrophage antigen presentation analyzed at the single-cell level. J Immunol 2003; 171:6706-6713.
53. NandanD, Lo R, ReinerNE. Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani. Infect Immun 1999; 67:4055-4063.
54. Pearson RD, Harcus JL, Roberts D et al. Differential survival of Leishmania donovani amastigotes in human monocytes. J Immunol 1983; 131:1994-1999.
55. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003; 3:23-35.
56. MartinezFO, SicaA, Mantovani A et al. Macrophage activation and polarization. Front Biosci 2008; 13:453-461.
57. MosserDM, Edwards JP.Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008; 8:958-969.
58. Rodriguez NE, Chang HK, Wilson ME. Novel program of macrophage gene expression induced by phagocytosis of Leishmania chagasi. Infect Immun 2004; 72:2111-2122.
59. Rodriguez NE, Gaur U, Wilson ME. Role of caveolae in Leishmania chagasi phagocytosis and intracellular survival in macrophages. Cell Microbiol 2006; 8:1106-1120.
60. Naroeni A, Porte F. Role of cholesterol and the ganglioside OMU) in entry and short-term survival of Brucella suis in murine macrophages. Infect Immun 2002; 70:1640-1644.
61. Rohde M, Muller E, Chhatwal Os et al. Host cell caveolae act as an entry-port for group A streptococci. Cell Microbiol 2003; 5:323-342.
62. Brittingham A, Chen G, McOwire B S et al. Interaction of Leishmania gp63 with cellular receptors for fibronectin. Infect Immun 1999; 67:4477-4484.
63. Harris J, Werling D, Hope JC et al. Caveolae and caveolin in immune cells: Distribution and functions. Trends Immunol 2002; 23:158-164.
64. Wilson ME, Pearson RD. Roles of CR3 and mannose receptors inthe attachment and ingestion of Leishmania donovani by human mononuclear phagocytes. Infect Immun 1988; 56:363-369.
65. Wozencrafi AO, Blackwell JM. Increased infectivity of stationary-phase promastigotes of Leishmania donovani: Conelation with enhanced C3 binding capacity and CR3-mediated attachment to host macrophages. Immunology 1987; 60:559-563.
66. Ueno N, Bratt CL, Rodriguez NE et al. Differences in human macrophage receptor usage, lysosomal fusion kinetics and survival between logarithmic and metacyclic Leishmania infantum chagasi promastigotes. Cell Microbiol 2009; 11:1827-1841.
67. Kima PE. The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist. Tnt J Parasitol 2007; 37:1087-1096.
68. McConville MJ, de Souza D, Saunders E et al. Living in a phagolysosome; metabolism of Leishmania amastigotes. Trends Parasitol 2007; 23:368-375.
69. Naderer T. McConville MJ. The Leishmania-macrophage interaction: A metabolic perspective. Cell Microbiol 2008; 10:30 1-308.
70. Tanowitz HB, Machado FS, Jelicks LA et al. Perspectives on Trypanosoma cruzi-induced heart disease (Chagas disease). Prog Cardiovasc Dis 2009; 5 1:524-539.
71. VaidianAK, Weiss LM, Tanowitz HB. Chagas' disease and AIDS. Kinetoplastid Biol Dis 2004; 13;(31):2.
72. Sartori AM, Ibrahim KY, Nunes Westphalen EV et al. Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV AIDS. Ann Trop Med Parasitol 2007; 101(1):31-50.
73. Huang H, Chan J, Wittner M et al. Expression of cardiac cytokines and inducible form of nitric oxide synthase (N052) in Trypanosoma cruzi-infected mice. J Mol Cell Cardiol 1999; 31:75-88.
74. Machado FS, Souto JT, Rossi MA et al. Nitric oxide synthase-2 modulates chemokine production by Trypanosoma cruzi-infected cardiac myocytes. Microbes Infect 2008; 10:1558-1566.
75. Hulit J, Bash T, Fu M et al. The cyclin Dl gene is transcriptionally repressed by caveolin-1. J Biol Chem 2000; 275:21203-21209.
76. Cohen AW, Park DS, Woodman SE et al. Caveolin-1 null mice develop cardiac hypertrophy ith hyperactivation of p42 44 MAP kinase in cardiac fibroblasts. Am J Physiol Cell Physiol 2003; 284: C45 7-474.
77. ParkDA, Woodman SE, SchubertW et al. Caveoilin-1 3 double knockoutmice are viable,but lack both muscle and non Muscle caveolae and develop a severe cardiomyopathi cphenotype.Am J Pathol 2002; 160:2207-2217.
78. Woodman, SE, ParkDS, Cohen AW et al. Caveolin-3 Knock-out Mice Develop a Progressive Cardiomyopathy and Show Hyper-activation of the p42 44 MAP kinase cascade. J Biol Chem 2002; 277:38988-38997.
79. Nagajyothi F, Desruisseaux M, Bouzahzah B et al. Cyclin and caveolin expression in an acute model of murine Chagasic myocarditis. Cell Cycle 2006; 5:107-112.
80. Huang H, Petkova SB, Cohen AW et al. Activation of Transcription factors (AP-1 and NF-icB) in Murine Chagasic Myocarditis. Activation of transcription factorsAP-1 andNF-icB in murine Chagasic myocarditis. Infect Immun 2003;71:2859-2567.
81. Adesse D, Lisanti MP, Spray DC et al. Trypanosoma cruzi infection results in the reduced expression of caveolin-3 in the heart. Cell Cycle 2010; 9:1639-1649.
82. Hassan OS, Mukherjee S, Nagajyothi F et al. Trypanosoma cruzi infection induces proliferation of vascular smooth muscle cells. Infect Immun 2006; 74:152-159.
83. Mukherjee S, Huang H, Petkova SB et al. Trypanosoma cruzi infection activates extracellular signal-regulated kinase in cultured endothelial and smooth muscle cells. Infect Immun 2004; 72:5274-5282.
84. Medina FA, Cohen AW, de Almeida CJ et al. Immune dysfunction in caveolin-1 null mice following infection with Trypanosoma cruzi (Tulahuen strain). Microbes Infect 2007; 9:325-333.
85. Banias ES, Dutra JM, Dc Souza W et al. Participation of macrophage membrane rafis in Trypanosoma cruzi invasion process. Biochem Biophys Res Commun 2007; 363:828-834.
86. Toxoplasma gondii. The Model Apieomplexao: Perspeetives and Methods. Weiss LM, Kim K, eds. Loodoo: Academic Press, 2007.
87. Wong SY, Remington JS. Biology of Toxoplasma gondii. AIDS 1993; 7(3):299-316.
88. Luff BJ, Hafner R, Korzun AH et al. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. N Engi J Med 1993; 329:995-1000.
89. Frenkel JK, Escajadillo A. Cyst ruptureas a pathogenic mechanismof toxoplasmic encephalitis. Am J Trop Med Hyg 1987; 36:517-522.
90. Ferguson DJ, HutchisonWM, Pettersen E. Tissue cyst rupture inmice chronically infectedwith Toxoplasma gondii. An immunocytochemical and ultrastructural study. Parasitol Res 1989; 75:599-603.
91. Weiss LM, Kim K. The development and biology of bradyzoites of Toxoplasma gondii. Front Biosci 2000; 5:D391-405.
92. Dubey JP. Advances in the life cycle of Toxoplasma gondii. Int J Parasitol 1998; 28:1019-1024.
93. Dubey JP, Lindsay DS, Speer CA. Structures of Toxoplasma gondii tachyzoites, bradyzoites and sporozoites and biology and development of tissue cysts. Clin Microbiol Rev 1998; 11:267-99.
94. Joiner KA, Fuhrman SA, Mietinnen H et al. Toxoplasma gondii: Fusion competence of parasitophorous vacuoles in Fc receptor transfected fibroblasts. Science 1990; 249:641-646.
95. Dobrowolski JM, Sibley LD. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell 1996; 84:933-939.
96. Dobrowolsk, JM, Carruthers VB, Sibley LD. Participation of myosin in gliding motility and host cell invasion by Toxoplasma gondii. Mol Microbiol 1997; 26:163-173.
97. Dubremetz JF, Achbarou A, Bermudes D et al. Kinetics and pattern of organelle exocytosis during Toxoplasma gondiithost-cell interaction. Parasitol Res 1993; 79:402-408.
98. Carruthers VB, Sibley LD. Sequential protein secretion from three distinct organelles of Toxoplasma gondii accompanies invasion of human fibroblasts. Eur J Cell Bio 1997; 73:114-123.
99. Norkin LC. Caveolae in the uptake and targeting of infectious agents and secreted toxins. Adv Drug Dcliv Rev 2001; 49:301-315.
100. Samuel BU, Mohandas N, Harrison T et al. The role of cholesterol and glycosylphosphatidylinositolanchored proteins of erythrocyte rafis in regulating rafi protein content and malarial infection. J Biol Chem 2001; 276, 293 19-29329.
101. Coppens I, Sinai AP, Joiner KA. Toxoplasma gondii exploits host lowdensity lipoprotein receptor-mediated endocytosis for cholesterol acquisition. J Cell Biol 2000; 149: 167-180.
102. Chanon AJ, Sibley LD. Host cells: Mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J Cell Sci 2002; 115:3049-3059.
103. Chang WJ, Rothberg KG, Kamen BA et al. Lowering the cholesterol content of MA 104 cells inhibits receptor-mediated transport of folate. J Cell Biol 1992; 118:63-69.
104. Sleat DE, Wiseman JA, El-Banna M et al. Genetic evidence for nonredundant functional cooperativity between NPC1 and NPC2 in lipid transport. Proc Natl Acad Sci U S A 2004; 101:5886-5891.
105. Ikonen E, Heino S, Lusa S. Caveolins and membrane cholesterol. Biochem Soc Trans 2004; 32:121-123.
106. Coppens I, Vielemeyer O. Insights into unique physiological features of neutral lipids in Apicomplexa: From storage to potential mediation in parasite metabolic activities. Int J Parasitol 2005; 35:5.
107. Sehgal A, Bettio S, Pypaert M et al. Peculiarities of host cholesterol transport to the unique intracellular vacuole containing Toxoplasma. Trafuc 2005; 6:1125-1141. 97-615.
108. Que X, Ngo H, Lawton Jet al. The cathepsin B of Toxoplasma gondii, toxopain-1, is critical for parasite invasion and rhoptry protein processing. J Biol Chem 2002; 277:25791-25797.
109. Hoppe H, Ngo HM, Yang M. Targeting to rhoptry organelles of Toxoplasma gondii involves evolutionarily conserved mechanisms. Nat Cell Biol 2001; 2:449-456.
110. Nichols BA, Chiappino ML, O'Connor GR. Secretion from the rhoptries of Toxoplasma gondii during host-cell invasion. J Ultrastruct Res 1983; 83:85-98.
111. Porchet-Hennere E, TorpierG. Relations entre Toxoplasmaet sacellule-hote. Protistologica 1983; 19:357-370.
112. Foussard F, Leriche MA, Dubremetz JF. Characterization of the lipid content of Toxoplasma gondii rhoptries. Parasitology 1992; 102;367-370.
113. Coppens I, Joiner KA. Host but not parasite cholesterol controls Toxoplasma cell entry by modulating organelle discharge. Mol Biol Cell 2003; 14:3 804-3820.
114. Suss-Toby E, Zimmerberg J, Ward GE. Toxoplasma invasion: The parasitophorous vacuole is formed from host cell plasma membrane and pinches off via a fission pore. Proc Natl Acad Sci U S A 1996; 93: 84 13-84 18.
115. Mordue DG, Desai N, Dustin M et al. Invasion by Toxoplasma gondii establishes a moving junction that selectively excludes host cell plasma membrane proteins on the basis of their membrane anchoring. J Exp Med 1999; 190:1783-1792.
116. Mordue DG, Hakansson S Niesman I et al. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafucking pathways. Exp Parasitol 1999; 92:87-99.
117. Ward GE, MillerLH, DvorakJA. The origin of parasitophorous vacuole membrane lipids in malaria-infected erythrocytes. J Cell Sci 1993;106:237-248.
118. Aikawa M, Komata Y, Asai T et al. Transmission and scanning electron microscopy of host cell entry by Toxoplasma gondii. Am J Pathol 1977; 87:285-296.
119. Bannister LH, Mitchell OH, Butcher GA et al. Lamellar membranes associated with rhoptries in erythrocytic merozoites of Plasmodium knowlesi: A clue to the mechanism of invasion. Parasitology 1986; 92:291-303.
120. Beckers CJ, Dubremetz JF, Mercereau-Puijalon O et al. The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite and is exposed to the host cell cytoplasm. J Cell Biol 1984; 127:947-96 1.
121. Hakansson S, Chanon AJ, Sibley LD. Toxoplasma vacuoles: A two-step process of secretion and fusion forms the parasitophorous vacuole. EMBO J 2001; 20:3132-3144.
122. Lisanti MP, Scherer PE, Vidugiriene Jet al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J Cell Bio 1994; 126:111-126.
123. Sargiacomo M, Sudol M, Tang ZL et al. Signal transducing molecules and OPT-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 1993; 122:789-807.
124. Li S, Okamoto T, Chun M et al. Evidence for a regulated interaction of hetero-trimeric 0 proteins with caveolin. J Biol Chem 1995; 270:15693-15701.
125. Wachtler V, Balasubramanian MK.Yeast lipid rafls?-an emerging view. Rends Cell Biol 2006; 6:1-4.
126. Aliberti J, Reis e Sousa C, Schito M et al. CCR5 provides a signal for microbial induced production of TL-12 by CD8cz+ dendritic cells. Nat Tmmunol 2000; 1:83-87.
127. Mazza PK, Straus AH, Toledo MS et al. Tnteraction of epithelial cell membrane rafts with Paracoccidioides brasiliensis leads to fungal adhesion and Src-family kinase activation. Microbes Tnfect 2008; 10:540-547.
128. Settnes OP, Nielsen MJ. Host-parasite relationship in Pneumocystis carinii infection: Activation of the plasmalemmal vesicular system in type I alveolar epithelial cells. J Protozool 1991; 38:174S-176S.
129. Twabuchi K, Prinetti A, Sonnino S et al. Involvement of very long fatty acid-containing lactosylceramide in lactosylceramide-mediatedsuperoxide generation and migration in neutrophils. Glycoconj J2008; 25:357-374.
130. Sato T, Twabuchi K,Nagaokal et al. Induction of human neutrophil chemotaxisby Candidaalbicans-derived 3-1,6-long glycoside side-chain-branched 3-glucan. J Leukoc Biol 2006; 80:204-2 11.
131. Beck MR, Dekoster GT, Cistola DP et al. NMR structure of a fungal virulence factor reveals structural homology with mammalian saposin B. Mol Microbiol 2009; 72:344-353.